Guido Di Dalmazi retweetledi

💊SGLT2i pleiotropic effects have demonstrated efficacy across various cardiovascular conditions, ranging from acute to chronic coronary syndromes and extending to arrhythmias, valvular heart disease, cardiomyopathies, cardio-oncology, and cerebrovascular disease!
🔍Our review provides an overview of the current literature on the potential mechanisms underlying the effectiveness of SGLT2i across a wide range of cardiovascular diseases, beyond HF.
@ELS_Cardiology @ElsevierConnect @matt_armi @CarminePizzi @L_Bergamaschi
#Pharmacology #ClinicalPharmacology #DrugDevelopment #SGLT2i
Cardiovascular therapeutic targets of sodium-glucose co-transporter 2 ... sciencedirect.com/science/articl…

English

























